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Arsenic is one of the most environmentally significant toxins and a great global health 
concern. Long known for its acute toxicity, arsenic has also been discovered to be a potent 
carcinogen. Evidence links arsenic toxicity and carcinogenic actions to reactive oxygen species 
(ROS). In most animal including humans, arsenic undergoes a biomethylation to yield organic 
arsenic species, long assumed to be a process of detoxification. However, a growing body of 
evidence suggests that these organic arsenic species, particularly the reduced trivalent 
intermediates, may be just as if not more toxic than the inorganic analogs. Furthermore, current 
food safety regulations often monitor only inorganic arsenic levels. There is, therefore, a clear 
need for more literature and empirical data concerning the toxic mechanisms of arsenic. 
 In this study, we examined organic and inorganic arsenites capacity to generate ROS 
when exposed to common oxidizing agents via EPR spectroscopy and spin-trapping with the 
cyclic nitrone 5,5-dimethyl-1-pyrroline-N-oxide (DMPO). Experimental observations were 
theoretically rationalized using density functional theory approach.  
 
 
 
 
 
 
 
Introduction 
As a naturally occurring element abundant in the earth’s crust, arsenic and its compounds 
are environmentally pervasive health hazards. Long known for its acute toxicity, arsenic is also 
understood to act as a potent carcinogen, even at sublevel concentrations. Studies of long-term 
exposure in humans associate arsenic with skin, bladder, lung, liver, colon, prostate, and kidney 
cancers.
1-5
 Besides a possible role in causing cancer, arsenic exposure has also been linked to 
hypertension, cardiovascular diseases, diabetes, and the unique vaso-occlusive Blackfoot 
disease
6, 7
 where undernourished populations are believed to be at a higher risk for developing 
these conditions.
8
 Hence, the monitoring of levels of arsenic in food, water, and soil is of 
tremendous importance, particularly in developing countries. The urgency of this global health 
initiative has renewed interest in arsenic chemistry, particularly for the purposes of elucidating 
the mechanism of its carcinogenic properties.  
Inorganic arsenic in the environment typically exists as the pentavalent As
V
 (arsenic acid, 
H3AsO4) or the trivalent As
III
 (arsenous acid, H3AsO3).
9
 Of the two forms, As
III
 (or as it is more 
commonly named by its conjugate base arsenite) is more toxic and mobile and remains in tissues 
longer.
10
 Once inhaled or ingested, inorganic arsenic is transformed to organic arsenic via a 
series of enzyme-catalyzed successive reduction and methylation steps (Scheme 1).
11, 12
 Initially 
believed to be a detoxification mechanism, it has been realized that the organic trivalent arsenic 
species monomethylarsonous acid (MMA
III
) and dimethylarsinous acid (DMA
III
) are the most 
toxic of all arsenic metabolites detected in human and animal urine.
13-17
  Variations at certain 
points in the human arsenic methyltransferase (AS3MT) gene may cause differences in 
methylating ability between individuals,
18
  but data suggests a standard profile of urinary arsenic 
humans as 10-30% inorganic, 10-20% MMA
(III+V)
, and 60-80% DMA
(III+V)
.
19
 The acute toxicity 
of inorganic As
V 
has been understood in its capacity to replace phosphate in biomolecules and to 
uncouple ATP via so-called arsenolysis. Compounding the lack of information is the apparent 
paradoxical dual-action of arsenic as both carcinogen and chemotherapeutic agent. Despite the 
plethora of evidence linking arsenic exposure to the development of various cancers, inorganic 
arsenite remains one of the most effective treatments for certain cancers, including acute 
promyelocytic leukemia (APL).
20-24
   
A growing body of evidence suggests that both the apoptosis-inducing antitumor effects 
and the genotoxic effects of arsenite and other arsenic metabolites are mediated via ROS and 
oxidative stress pathways.
5, 25-35
 Recent evidence also suggests that biomethylation of arsenic 
may be responsible for the observed carcinogenicity.
36, 37
 However, it is currently not known 
which specific form (or forms) of arsenite is responsible for the observed antitumor and 
genotoxic effects due to the various transformations arsenic undergoes in vivo. Furthermore, 
there is a current lack of literature concerning the structural differences between the organic and 
inorganic arsenites and the effects of structure on capacity to generate ROS. Gaining greater 
understanding of the electronic properties, reactivities, and differences therein of the inorganic 
and organic arsenic radical species may help to elucidate arsenic’s toxic mechanisms. We used 
electron paramagnetic resonance (EPR) spectroscopy and the spin trap 5,5-dimethyl-1-pyrroline-
N-oxide (DMPO) to study the free radical activity of As
III
 and DMA
III
 in aqueous solution. We 
also performed theoretical calculations on the structures and thermodynamics of the arsenic 
species involved in several proposed mechanisms of oxidation and radical generation as well as 
theoretical analysis of the spin adducts experimentally generated. We have identified trends in 
ROS activity that closely correlate to trends in the experimental data as a function of degree of 
methylation.  
Experimental Procedures 
 General Computational Methods. All calculations were performed at the Ohio 
Supercomputer Center using Gaussian 09. 
38
  Density functional theory
39, 40
 was applied in this 
study to determine the optimized geometry, vibrational frequencies, and single-point energy of 
all stationary points.
41-44
 Single-point energies were obtained at the B3LYP/6-31+G** level 
based on the optimized B3LYP/6-31G* geometries, and the B3LYP/6-31+G**// B3LYP/6-31G* 
wave functions were used for Natural Population Analyses (NPA).
45
 The effect of solvation on 
the gaseous phase calculations was also investigated using the polarizable continuum model 
(PCM).
46-50
 The B3LYP level was employed based on previous studies demonstrating the 
appropriateness of this level for the study of H2AsO radical compared to other more powerful 
levels of theory.
51
 The 6-31G* basis set was chosen for its computational speed and its good 
agreement with experimentally determined bond lengths and angles for the third row atoms.
52
 
These basis set calculations used the standard six Cartesian d functions. Vibrational frequency 
analyses (B3LYP/6-31G*) for each of the stationary points for all arsenic species and for DMPO 
and its spin adducts yielded no imaginary vibrational frequencies. A scaling factor of 0.9806 was 
used for the zero-point vibrational energy (ZPE) corrections with the B3LYP/6-31G*.
53
 
Calculation of Isotropic Hyperfine Coupling Constants (hfcc).  The prediction of hfcc 
of the nitrogen atom in simple nitroxides was demonstrated in several benchmark works.
49, 54-56
 
Based on these previous studies, we employed similar models in the prediction of hfcc’s of the 
nitrogen, β-hydrogen and γ-hydrogens of possible DMPO adducts  of radical species produced 
by the oxidation of As
III
 and DMA
III
 in water. A discussion of the comparative study of the 
calculated hfcc’s for DMPO-O2H optimized at the B3LYP density functional and basis sets, 6-
31+G**, 6-31G*, EPR-II and EPR-III,
57
 and the core-valence correlation-consistent cc-pCVDZ
58
 
in the gas and aqueous phases can be found in pages S13-S18 of the Supplementary Material 
Section of our previous paper.
59
 In the same article,
59
 the hybrid PBE0 functional and EPR-II 
basis set was found
56
 to yield accurate aN values in simple nitroxides and was also employed in 
the calculation of hfcc’s for DMPO-O2H. Although the levels of theory mentioned above gave 
accurate aN for 2,2,5,5-substituted pyrrolidine nitroxides, the calculated hfcc’s for DMPO-O2H 
using the same levels of theory gave hfcc’s comparable to that predicted at B3LYP/6-
31+G**//B3LYP/6-31G*. Hence, in this study, the aN, aβ-H and aγ-H for all of the spin adducts 
were only calculated at the B3LYP/6-31+G**//B3LYP/6-31G* level to show qualitative trends 
in the hfcc compared to the experimental.      
EPR Measurements. EPR measurements were carried out on an X-band spectrometer 
with HS resonator at room temperature. General instrument settings are as follows unless 
otherwise noted: microwave power, 10 mW; modulation amplitude, 0.5 G; receiver gain 3.17-
3.56 x 10
5
, time constant, 82 ms, time sweep 42 s. The hyperfine splittings (hfcc) of the spin 
adducts were determined by simulating the spectra using an automatic fitting program.
60
  
 Spin Trapping Studies. DMPO, As2O3, cacodylic acid ((CH3)2AsOOH), and 80% H2O2 
were all commercially obtained. Dimethylarsinous acid was prepared by allowing 
dimethyliodoarsine, (CH3)2AsI, to hydrolyze in solution. Dimethyliodoarsine was prepared by 
reduction of cacodylic acid following a previously established procedure
61
  and purity of the 
product was confirmed by GC/MS. All solutions for spin trapping were prepared using 
Dulbecco’s phosphate buffered saline solution at pH 7.4. The total volume of each solution used 
for the EPR measurement was 50 L, and was loaded into a 50 L quartz micropipette. All 
samples contain 100 mM arsenite species concentration and 100 mM DMPO in aerobic PBS. 
Experimental conditions were as follows: DMPO and As2O3; DMPO, As2O3 and 0.2% H2O2; 
DMPO, As2O3, 0.2% H2O2 and 3.5 mM Fe
II
; DMPO, As2O3, and 3.5 mM Fe
II
.  Experiments 
were repeated with (CH3)2AsOH in place of arsenite. Negative controls used DMPO in pure 
PBS. Positive control used DMPO in the presence of H2O2 and irradiation with 254 nm light.  
 
Results and Discussion 
 Spin trapping. Spin trapping with DMPO in aqueous solutions of trivalent arsenic 
yielded various spin adducts, however, no arsenic-centered radicals were detected in this way 
due to the absence of splitting pattern from 
75
As with IAs = 3/2. Trivalent arsenic is a 
demonstrably powerful reducing agent and single electron transfers to ROS such as HO
•
 have 
been demonstrated to be highly kinetically favorable.
62
  
Spin trapping of a solution containing DMA
III
, H2O2, and in the presence or absence of 
Fe
II 
yielded an acylnitroxide adduct (Figure 1)
63
  that is likely formed from the hydrolysis of 
superoxide (O2
•–
) or peroxyl (HO2
•
)
 
radical adducts. Spin trapping of a solution containing 
DMA
III
 and Fe
II
 yielded predominantly HO
•64
 and C-centered
 
adduct (Figure 2).
65
  Spin trapping 
of a solution containing DMPO and DMA
III
 yielded HO
•
 as the major species with minor species 
of alkyl radical adduct (Figure 3). Spin trapping of a solution containing As
III
, H2O2, and Fe
II 
yielded predominantly HO
•
 adduct and C-centered adduct, with open chain nitrone
63, 66
 and HO2
•
 
adduct as minor species (Figure 4). The presence of the open chain nitrone is suggested as the 
source of the carbon-centered adduct.
67
 Spin trapping of a solution containing As
III
 and H2O2 
yielded mostly HO
• 
adduct, and also open chain nitrone and C-centered adduct (Figure 5).  Spin 
trapping of a solution containing As
III
 and Fe
II 
yielded mostly HO
•
 radical adduct and C-centered
 
adduct, with minor products being open chain nitrone and HO2
•
 adduct (Figure 6).  Spin trapping 
of a solution containing DMPO and As
III
 gave mostly HO
•
, with a minor species of C-centered
 
adduct and possible open chain nitrone (Figure 7). We found no evidence of adducts formed 
between the nitrone and any As-containing radical compounds. We propose that the trapped 
ROS’s were generated as byproducts of a rapid oxidation of trivalent to pentavalent arsenic.  
The appearance of open-chain nitrones and C-centered adducts is proposed to be the 
result of reductive DMPO
•
-OOH decomposition. This decomposition has been shown to occur 
via a ring-opening mechanism, leading to carbon-centered radicals.
66
  Once formed, such 
radicals would be rapidly trapped. Decomposition analysis of adducts formed in a solution 
containing As
III
, H2O2, and Fe
II
 supports this hypothesis as O2
•–
 adduct decomposes to form the 
open chain nitrone (Figure 8). However, one would expect a proportionate formation of C-
centered radical adduct with ring-opening, but an inverse relationship exists there too, with C-
centered adduct being present in detectable quantity only for the first 200s of the experiment.  
 Theoretical Studies. Theoretical analysis of the electronic structures of various proposed 
As
IV
 radical intermediates was carried out at the PCM/B3LYP/6-31G**//B3LYP/6-31G* level of 
theory (Figure 7). For a more systematic model of the effect of methylation on arsenic toxicity, 
monomethyl arsenic species were included in the calculations. Trends in structure and reactivity 
were readily observed. The neutral tetravalent species (formed by one electron oxidation of the 
corresponding trivalent species via radical addition of hydroxyl radical to the As atom) exhibited 
a see-saw molecular geometry with methyl groups always located equatorially. An analysis of 
electron spin-density revealed the axial oxygen atoms to have greater spin density compared to 
the nonexistent spin on the equatorial oxygens (as in As
III
 and MMA
III
). Additionally, increasing 
methylation character was proportional to an increase in spin density on the As atom. This may 
be explained by the increased As-OH axial bond lengths with methylation character caused by 
the bulky equatorial methyl groups and by the electron donating effect of the methyl groups. The 
cationic tetravalent intermediates exhibited the same trend in increasing As spin density with 
increasing methyl substitution, although spin density is evenly distributed across the oxygen 
atoms arranged in a trigonal pyramidal molecular geometry.  
 We examined (at the same level of theory) the mechanisms of generation of the 
tetravalent arsenic radical intermediates and subsequent oxidation to the pentavalent arsenics 
with radical products including superoxide and hydroperoxyl radical. The mechanisms examined 
used common oxidants including O2, O2
•-
, and H2O2/HO
•
 which have been previously established 
as causal agents in the oxidation of As
III
 to As
V
, with As
IV
 the proposed intermediate.
68
 The 
mechanisms and results, shown in Tables 1-3, reveal an important trend: increasing methyl 
character of the starting trivalent arsenic species is proportional to increasing exoergicity of 
reaction. Thus, oxidation from trivalent to pentavalent arsenic and subsequent generation of 
reactive oxygen species byproducts is more energetically favorable with increasing methyl 
substitution.  
 Increasing evidence
16, 69-71
 suggests that the organic trivalent arsenics are the most toxic 
of all common arsenic species. It has been proposed that this increased toxicity is due to the high 
membrane permeability of organic trivalent arsenics, with DMA
III
 being more permeable than 
MMA
III 
or As
III
.
72, 73
 However  recent studies present evidence that non-methylating urothelial 
cells are less susceptible to As
III 
exposure than methylating heptocytes.
74
 This is interesting 
because it means that the methylation occurs only after the inorganic arsenite has already 
permeated the membrane and is inside of the cell, suggesting that the increased toxicity of the 
methylated arsenites is due to its intrinsic toxic character rather than greater membrane 
permeability. Recent experiments have also shown that hepatocytes of catalase-knockout mice 
exposed to H2O2 or MMA
III
 exhibit significantly higher occurrences of DNA strand breaks than 
in wild type mice with the intact gene for catalase (catalase catalyses the conversion of H2O2 to 
oxygen and water, thus limiting the production of  damaging hydroxyl radical).
75
 In the same 
study, EPR spin trapping with DMPO of the cell contents showed the presence of  •OH  in 
hepatocytes of mice exposed to H2O2 or MMA
III
, the signal for which was greatly reduced in 
wild type mice versus catalase-knockout mice. This suggests that the genotoxic effects of organic 
arsenite exposure are mediated by ROS, in particular •OH.  In consideration of recent studies that 
link arsenic exposure to oxidative stress and ROS generation, we hold our study to be a timely 
and relevant contribution.  Our findings show that arsenites generate various ROS when exposed 
to common oxidants in solution.  Both H2O2 and O2 have previously been demonstrated to 
oxidize As
III 
to As
V
 and DMA
III 
to DMA
V68, 76
 and our theoretical calculations suggesting a basis 
for the increased redox activity of methylated arsenites can be applied to the observed trends in 
arsenic methylation and toxicity. That methylation appears to localize electron spin density on 
arsenic centered radicals may explain the increasing exoergicity of radical oxidation proportional 
to increasing methyl substitution of arsenite. In turn the increasing exoergicity of methylated 
arsenites oxidation in water and thus increasing ROS production may help to explain the trends 
in arsenic toxicity. Of additional interest is the application of inorganic arsenite as an effective 
chemotherapeutic agent in the treatment of acute promyelocytic leukemia,
20, 22
 which may seem 
counterintuitive as arsenite is known to be a potent human carcinogen. However, evidence 
suggests that the dose-response relationship induced by arsenic exposure is not linear, rather it is 
biphasic. Thus at low concentrations arsenite acts as a carcinogen, causing tumorigenesis by 
stimulating transcription factors that express genes promoting cell proliferation and malignant 
transformation and causing apoptosis at higher concentrations.
77, 78
 However, at higher 
concentrations arsenic acts to promote apoptosis by causing genomic instability.
79, 80
 More recent 
evidence pinpoints at least one biphasic mechanism by which arsenic acts to promote and 
suppress proliferation with inceasing concentrations: in human keratinocytes exposed to low 
levels or arsenite, there is inactivation of the tumor suppressor protein p53 (an inhibitor of 
survivin) and correspondingly heightened levels of survivin (mediator of apoptosis resitance, 
highly expressed in cancer cells) while higher concentrations sees the oppostive effect: high 
activation of p53 and negative regulation of survivin.
81
 However, it must be noted that these 
studies cannot pinpoint the exact species (or multiples species) of arsenic (be it inorganic or 
biomethylated, tri- or penta- valent) responsible for these effects. For example, the urine of acute 
promyelocytic leukemia patients treated with inorganic arsenite has been found to contain 
considerable levels of methylated arsenic.
82
  
 Another study compared gene expression and cell viability between iAs
III
, MMA
III
, and 
DMA
III
 in human keratinocytes.
83
 After analyzing trends in cell proliferation, apoptosis, and the 
expression of genes promoting cellular oxidative defense, apoptosis factors and growth factors, 
the study’s authors concluded that  MMAIII was the most cytotoxic species (LC50 = 2.8µM) , 
followed by DMA
III 
(LC50 = 5.6µM), and then iAs
III
 (LC50 = 17µM). In human bladder cancer 
cells, treatment with DMA
III
  or DMMTA
V
 (dimethylmonothioarsinic acid)  drastically reduced 
GSH and p53 levels compared to control cells, while iAs also decreased p53 it was not as drastic 
as DMA
III
 and treatment actually increased GSH levels compared to control.
15
  One should not 
compare these results with the previously described study in human keratinocytes as the cancer 
cells have already demonstrated a compromised oncosuppresive system so further toxic insult is 
not likely to produce the response seen in normal cells exposed to high levels of arsenic. The 
Authors of this study suggest that the increased toxicity of the organic arsenicals was occurring 
via a cycle of GSH depletion from catalyzed reduction of DMA
V
 to DMA
III 
and subsequent 
regeneration of the trivalent form. Our theoretical results corroborate this finding, we found the 
oxidation of DMA
III 
to DMA
V 
to be highly exoergic in multiple redox pathways. Our results also 
suggest a similar ROS speciation between iAs
III
 and DMA
III
, with no difference in signal 
intensity (as would be expected from our calculations, the oxidation from tri to pentavalent 
arsenical is highly exoergic for both species). 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
Scheme 1. Biomethylation of arsenic in humans. The reduction steps are catalyzed by As
V 
reductase, the oxidative methylation steps are catalyzed by As
III
 methyltransferase, with S-
adenosyl methionine (SAM) as the methyl donor demethylated to S-adenosyl-L-homocysteine 
(SAH).Reduced glutathione (GSH) serves as the electron donor.
17
  
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Figure 1. Simulated (top) and experimental (bottom) EPR spectrum of a solution containing 
DMPO, DMA
III
, and H2O2 showing a spectral profile and splitting parameters characteristic of 
the oxidized DMPO radical adduct DMPOX: aN = 9.1G, aβ-H = 5.1G, aγ-H = 5.0 G. 
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Figure 2.  (a) Experimental and (b) simulated EPR spectrum of a solution containing DMPO, 
DMA
III
, and Fe
II
. Simulation of the spectrum components (c) hydroxyl radical adduct (76.4%):  
aN = 15.1 G, aβ-H = 14.5 G; (d) alkyl radical adduct (23.6%) : aN = 15.5 G, aβ-H = 22.5 G.   
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Figure 3.  (a) Experimental and (b) simulated EPR spectrum of a solution containing DMPO and 
DMA
III
. Simulation of the spectrum components (c) hydroxyl radical adduct (81.6%):  aN = 15.0 
G, aβ-H = 14.5 G; (d) alkyl radical adduct (18.4%) : aN = 14.5 G, aβ-H = 22.8 G.   
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Figure 4. (a) Experimental and (b) simulated EPR spectrum of a solution containing DMPO, 
As
III
, H2O2, and Fe
II
. Simulation of the spectrum components (c) hydroxyl radical adduct 
(32.2%):  aN = 15.9 G, aβ-H = 15.7 G; (d) alkyl radical adduct (27.5%) : aN = 16.2 G, aβ-H = 23.0 
G; (e) open chain-nitrone (30.6%): aN = 15.8 G, aβ-H = 2.1G; (f) hydroperoxyl radical adduct 
(9.7%): aN = 14.6 G, aβ-H = 9.8 G, aγ-H = 1.4 G. 
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Figure 5. (a) Experimental and (b) simulated EPR spectrum of a solution containing DMPO, 
As
III
, and H2O2. Simulation of the spectrum components (c) hydroxyl radical adduct (37.5%):  aN 
= 15.9 G, aβ-H = 16.2 G; (d) open chain-nitrone (31.6%): aN = 15.5 G, aβ-H = 2.5 G; (e) alkyl 
radical adduct (30.9%) : aN = 16.1 G, aβ-H = 22.9 G.  
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Figure 6. (a) Experimental and (b) simulated EPR spectrum of DMPO, As
III
, and Fe
II
 in aqueous 
solution. Simulation of the spectrum components (c) hydroxyl radical adduct (44.3%):  aN = 15.9 
G, aβ-H = 15.9 G; (d) alkyl radical adduct (37.4%) : aN = 15.8 G, aβ-H = 22.8 G; (e) open chain-
nitrone (13.3%): aN = 15.4 G, aβ-H = 3.4 G; (f) hydroperoxyl radical adduct (5.0%): aN = 15.6 G, 
aβ-H = 10.3 G, aγ-H = 2.2 G. 
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Figure 7. (a) Experimental and (b) simulated EPR spectrum of DMPO and As
III 
in aqueous 
solution. Simulation of the spectrum components (c) hydroxyl radical adduct (72.4%):  aN = 16.0 
G, aβ-H = 16.2 G; (d) alkyl radical adduct (20.4%) : aN = 15.4 G, aβ-H = 23.1 G; (e) open chain-
nitrone (7.2%): aN = 15.3 G, aβ-H = 2.8 G. 
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Figure 8. Decomposition of the various radical adducts in a solution containing DMPO, As
III
, 
H2O2, and Fe
II
. Notice the decomposition of DMPO
•
-OOH adduct in relationship to formation of 
the open-chain nitrone.  
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Figure 7. Aqueous phase bond distances, spin and charge (in parentheses) densities of various 
radicals at the PCM/B3LYP/6-31+G**//B3LYP/6-31G* level. Note the trend of increasing spin 
density on the As atom with increasing methyl substitution. Also note the absence of spin density 
on the equatorial oxygen atoms on the seesaw geometries of As
IV• 
and MMA
IV•
.  
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Table 1.  Free energies (in kcal/mol) of hydroxyl radical-initiated radical oxidation of arsenites 
at the PCM/B3LYP/6-31G**//B3LYP/6-31G* level of theory. 
 
 R1, R2 ∆G298K, I 
OH,OH -14.8 
OH, Me -20.0 
Me, Me -23.2 
 
 
R1, R2 ∆G298K, II   
OH,OH -10.7 
OH, Me -16.7 
Me, Me -18.9 
 
 ∆G298K, I + II  
-25.5 
-36.7 
-42.1 
 
 
 
 
 
 
 Table 2.  Free energies (in kcal/mol) of superoxide-initiated radical oxidation of arsenites at the 
PCM/B3LYP/6-31G**//B3LYP/6-31G* level of theory. 
 R1, R2 ∆G298K, I 
OH,OH 25.4 
OH, Me 8.4 
Me, Me -3.1 
 
 R1, R2 ∆G298K, II 
OH,OH -62.1 
OH, Me -50.3 
Me, Me -42.0 
 
 R1, R2 ∆G298K, III 
OH,OH -10.7 
OH, Me -16.7 
Me, Me -18.9 
 
 ∆G298K, I + II + III 
-47.4 
-58.6 
-64.0 
 
 
 
 
 
 
  
Table 3.  Free energies (in kcal/mol) of oxygen-initiated radical oxidation of arsenites at the 
PCM/B3LYP/6-31G**//B3LYP/6-31G* level of theory. 
 R1, R2 ∆G298K, I 
OH,OH 81.4 
OH, Me 64.4 
Me, Me 52.9 
 
 R1, R2 ∆G298K, II 
OH,OH -62.1 
OH, Me -50.3 
Me, Me -41.9 
 
 R1, R2 ∆G298K, III 
OH,OH -10.7 
OH, Me -16.7 
Me, Me -18.9 
 
 ∆G298K, I + II + III 
(kcal/mol) 
8.6 
-2.6 
-7.9 
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